Current Pharmacogenomics and Personalized Medicine
Title:Editorial: Questioning the Governance of Pharmacogenomics and Personalized Medicine for Global Health
Volume: 11 Issue: 4
Author(s): Edward S. Dove
Affiliation:
Keywords: Emerging biotechnologies, global health, governance, knowledge-based innovation, personalized medicine, pharmacogenomics.
Export Options
About this article
Cite this article as:
Dove S. Edward, Editorial: Questioning the Governance of Pharmacogenomics and Personalized Medicine for Global Health, Current Pharmacogenomics and Personalized Medicine 2013; 11 (4) . https://dx.doi.org/10.2174/1875692111999131125160410
DOI https://dx.doi.org/10.2174/1875692111999131125160410 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Multiple Sclerosis: Risk Factors and their Interactions
CNS & Neurological Disorders - Drug Targets Dynamic Role of Macrophage Sub Types on Development of Atherosclerosis and Potential Use of Herbal Immunomodulators as Imminent Therapeutic Strategy
Cardiovascular & Hematological Agents in Medicinal Chemistry Psychosocial Factors and Diabetes Mellitus: Evidence-Based Treatment Guidelines
Current Diabetes Reviews Binding Site Detection and Druggability Prediction of Protein Targets for Structure- Based Drug Design
Current Pharmaceutical Design Meet the Editorial Board
CNS & Neurological Disorders - Drug Targets Infectious Complications with Anti-TNFα Therapy in Rheumatic Diseases: A Review
Recent Patents on Inflammation & Allergy Drug Discovery Predicted Mechanism of Antiasthmatic Drugs in Depression Based on Their Interaction with SERT and 5-HT1A Receptors
Current Enzyme Inhibition Transcriptional Regulation Analysis of Alzheimer's Disease Based on FastNCA Algorithm
Current Bioinformatics Angelica Injection Promotes Peripheral Nerve Structure and Function Recovery with Increased Expressions of Nerve Growth Factor and Brain Derived Neurotrophic Factor in Diabetic Rats
Current Neurovascular Research Modulation of Transient Receptor Potential Vanilloid Subtype 1 (TRPV<sub>1</sub>) and Norepinephrine Transporters (NET) Protect Against Oxidative Stress, Cellular Injury, and Vascular Dementia
Current Neurovascular Research The Role of Neopterin in Atherogenesis and Cardiovascular Risk Assessment
Current Medicinal Chemistry Dietary Interventions for Diabetic Neuropathy & Nephropathy: A Review
Current Psychopharmacology Nuclear Factor-Kappa B: From Clone to Clinic
Current Molecular Medicine Proteins Expressed Differently Between Glucose and Glycerol for Schizochytrium limacinum SR21
Current Biotechnology Research on the Pathological Mechanism and Drug Treatment Mechanism of Depression
Current Neuropharmacology Studies on Drug-Drug Interactions, Presence and Absence of Diazepam (Site-II Specific Probe) Propranolol and Amitriptyline at Binding Sites of Bovine Serum Albumin
Current Drug Therapy Brain Arrhythmias Induced by Amyloid Beta and Inflammation: Involvement in Alzheimer’s Disease and Other Inflammation-related Pathologies
Current Alzheimer Research Up-Regulation of Hypoxia-Inducible Factor (HIF)-1α and HIF-Target Genes in Cortical Neurons by the Novel Multifunctional Iron Chelator Anti-Alzheimer Drug, M30
Current Alzheimer Research Therapeutic Potential of Cannabinoids in Schizophrenia
Recent Patents on CNS Drug Discovery (Discontinued) Inflammatory Mediators and the Failing Heart: A Translational Approach
Current Molecular Medicine